BN
Publicaties op Oncologisch.com
STELLAR: Fase III, Gerandomiseerde, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patiënt...
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a rando...
Vorasidenib bij IDH1/2-gemuteerd laaggradige glioom: INDIGO fase III